The Impact of Breast Cancer Diagnosis on Sexual Dysfunction

Article

Hadeel Assad, MD, hematology/oncology fellow, Providence Hospital and Medical Center, discusses an analysis of the impact of breast cancer diagnosis on sexual dysfunction.

Clinical Pearls

Hadeel Assad, MD, hematology/oncology fellow, Providence Hospital and Medical Center, discusses an analysis of the impact of breast cancer diagnosis on sexual dysfunction.

  • Sexual dysfunction is a common and under acknowledged disorder in women with breast cancer.
  • 45 women were assessed with an anonymous questionnaire.
  • Overall, 45% of women experienced a decline in sexual health. There was a more significant design after breast cancer treatment than after diagnosis.
  • Sexual dysfunction was addressed by the treating oncologist in 3 out of 45 women.

<<<

Back to the 2014 Breast Cancer Symposium conference page

Related Videos
Video 5 - "Second-Line Treatment Considerations and Improving Outcomes in Breast Cancer"
Video 4 - "Impressions on Safety Data from EMERALD Subgroup Analysis"
Video 2 - "Importance of Biomarker Testing in Breast Cancer"
Video 3 - "EMERALD: Elacestrant for ER+/HER2- Advanced Breast Cancer"
Video 1 - "Patient Profile: A 49-Year-Old Woman with HR+/HER2- mBC and Liver and Lung Metastases"
Video 7 - "Unmet Needs and Future Directions in HER2+ Breast Cancer"
Video 6 - "Current Approaches to Treatment Sequencing in HER2+ Breast Cancer"
Video 5 - "Exciting Developments in HER2+ Breast Cancer"
Related Content